Not Tagged
89bio
[]
two months after revealing the topline data and quickly going to the market for a capital infusion of $95 million 89bio is now presenting the mid-stage results of its high-triglyceride drug at #esc22. 
The biopharma world is here. Get the industry’s most comprehensive daily news report at https://t.co/rXFyNyZcJs